Estados financieros detallados de Korro Bio, Inc. (KRRO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Korro Bio, Inc. registró ingresos de $6.4M en el último ejercicio fiscal, con un CAGR de 5 años del -29.6%.
Márgenes de los últimos 12 meses: margen bruto 72.8%, margen operativo -31.8%, margen neto -44.8%.
Al precio actual de $13.83, KRRO presenta beneficios negativos (P/E no significativo) y un ROE del -114.26%. La capitalización bursátil es de $138M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $28.9M | $37.0M | 0 | 0 | 0 | $2.3M | $6.4M |
| Coste de Ventas | $531000 | $654000 | $16.8M | $1.6M | 0 | 0 | 0 | 0 | $4.3M |
| Beneficio Bruto | -$531000 | -$654000 | $12.1M | $35.4M | 0 | 0 | 0 | $2.3M | $2.1M |
| I+D | $11.8M | $11.6M | $18.3M | $36.7M | $23.8M | $42.2M | $57.2M | $63.6M | $65.6M |
| Generales y Administrativos | $4.0M | $6.7M | $14.5M | $26.3M | $11.7M | $16.8M | $36.5M | $30.5M | $28.2M |
| Gastos Operativos | $15.8M | $18.3M | $32.8M | $63.0M | $35.5M | $59.0M | $84.5M | $94.2M | $89.5M |
| Beneficio Operativo | -$16.3M | -$18.9M | -$20.7M | -$27.6M | -$35.5M | -$59.0M | -$84.5M | -$91.9M | -$87.3M |
| EBITDA | -$19.5M | -$18.4M | -$17.9M | -$24.9M | -$33.9M | -$56.5M | -$80.9M | -$88.3M | -$83.1M |
| Gastos por Intereses | $174000 | $106000 | 0 | 0 | 0 | $118000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$20.2M | -$19.2M | -$18.7M | -$26.5M | -$22.0M | -$58.0M | -$81.1M | -$83.4M | -$116.6M |
| Impuestos | 0 | 0 | 0 | $35000 | $2000 | $10000 | $27000 | $141000 | $637000 |
| Beneficio Neto | -$20.2M | -$19.2M | -$18.7M | -$26.5M | -$22.0M | -$58.0M | -$81.2M | -$83.6M | -$117.3M |
| BPA | $-32.27 | $-30.57 | $-30.39 | $-41.10 | $-4.94 | $-227.58 | $-53.09 | $-9.37 | $-12.48 |
| BPA Diluido | $-32.27 | $-30.57 | $-30.39 | $-41.10 | $-4.94 | $-227.42 | $-53.08 | $-9.37 | $-12.48 |
| Acciones en Circulación (Diluidas) | $627085 | $627085 | $616890 | $645064 | $4.4M | $255174 | $1.5M | $8.9M | $9.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $1.1M | $1.3M | 0 | 0 |
| Beneficio Bruto | $1.1M | $643000 | 0 | 0 |
| Beneficio Operativo | -$19.2M | -$15.9M | -$20.4M | -$20.1M |
| EBITDA | -$16.9M | -$15.2M | -$20.1M | -$19.7M |
| Beneficio Neto | -$18.1M | -$50.0M | -$19.6M | -$18.9M |
| BPA | $-1.92 | $-5.33 | $-1.69 | $-1.07 |
| BPA Diluido | $-1.92 | $-5.33 | $-1.69 | $-1.07 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $17.9M | $42.2M | $200.2M | $220.3M | $79.6M | $36.9M | $166.2M | $55.6M | $21.8M |
| Inversiones a Corto | 0 | 0 | $17.2M | 0 | $51.1M | $18.9M | 0 | $70.5M | $53.3M |
| Cuentas por Cobrar | 0 | $161000 | $805000 | $340000 | $144000 | 0 | 0 | $1.7M | $969000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $18.0M | $42.9M | $221.4M | $225.1M | $134.7M | $57.1M | $172.7M | $131.5M | $82.4M |
| Inmovilizado Material | $1.7M | $1.5M | $1.8M | $37.8M | $36.9M | $11.9M | $42.8M | $51.5M | $16.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $19.8M | $44.5M | $223.2M | $264.7M | $185.4M | $73.7M | $221.7M | $226.2M | $113.5M |
| Cuentas por Pagar | $994000 | $1.9M | $1.2M | $5.5M | $2.7M | $2.6M | $7.3M | $4.0M | $1.7M |
| Deuda a Corto | 0 | 0 | 0 | $397000 | $2.6M | $2.9M | 0 | 0 | 0 |
| Pasivos Corrientes | $2.2M | $3.8M | $52.8M | $26.6M | $11.4M | $8.7M | $19.5M | $15.0M | $11.9M |
| Deuda a Largo | $46.7M | $84.9M | 0 | $15.0M | $14.2M | $163.9M | 0 | 0 | 0 |
| Pasivos Totales | $49.4M | $89.1M | $55.9M | $72.2M | $54.5M | $172.8M | $51.8M | $65.8M | $62.1M |
| Reservas | -$29.9M | -$49.1M | -$68.9M | -$95.4M | -$180.1M | -$101.8M | -$183.0M | -$266.6M | -$383.8M |
| Patrimonio Neto | -$29.6M | -$48.3M | $167.4M | $192.5M | $130.8M | -$99.0M | $169.9M | $160.4M | $51.4M |
| Deuda Total | $46.7M | $84.9M | 0 | $46.0M | $45.6M | $167.0M | $33.2M | $44.8M | $43.5M |
| Deuda Neta | $28.8M | $42.7M | -$217.4M | -$174.3M | -$85.1M | $111.1M | -$132.9M | -$81.3M | -$31.7M |
| Capital Circulante | $15.7M | $39.2M | $168.6M | $198.4M | $123.3M | $48.4M | $153.2M | $116.6M | $70.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $25.2M | $21.8M | $61.7M | $24.9M |
| Activos Totales | $161.6M | $113.5M | $183.6M | $163.4M |
| Pasivos Totales | $62.5M | $62.1M | $64.0M | $60.2M |
| Patrimonio Neto | $99.0M | $51.4M | $119.6M | $103.2M |
| Deuda Total | $44.7M | $43.5M | $42.9M | $42.2M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$20.2M | -$19.2M | -$18.7M | -$10.2M | -$22.0M | -$58.0M | -$81.2M | -$83.6M | -$117.3M |
| Amortizaciones | $531000 | $654000 | $813000 | $1.6M | $1.6M | $2.5M | $3.6M | $3.6M | $3.8M |
| Compensación en Acciones | 0 | 0 | 0 | 0 | $807000 | $1.1M | $2.4M | $4.5M | $7.7M |
| Cambio en Capital Circulante | $276000 | $819000 | $48.6M | -$30.2M | $904000 | -$633000 | $4.3M | $13.6M | -$4.4M |
| Flujo de Caja Operativo | -$14.6M | -$17.0M | $34.2M | -$45.2M | -$32.1M | -$53.6M | -$67.3M | -$60.1M | -$78.6M |
| Inversiones (CapEx) | -$1.9M | -$436000 | -$1.1M | -$6.7M | -$4.4M | -$5.2M | -$7.8M | -$17.9M | -$518000 |
| Adquisiciones | 0 | $3.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$16.5M | -$17.5M | $33.2M | -$51.9M | -$36.5M | -$58.9M | -$75.1M | -$78.0M | -$79.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$17.2M | -$17.7M | -$16.1M | -$17.0M |
| Inversiones (CapEx) | -$175000 | -$84000 | -$21000 | -$37000 |
| Flujo de Caja Libre | -$17.4M | -$17.8M | -$16.1M | -$17.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $2.1M | $2.7M | $2.7M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | +27.8% | -100.0% | | | | +181.5% |
| Crecimiento Beneficio Neto (anual) | | +5.3% | +2.2% | -41.4% | +17.2% | -164.3% | -39.9% | -3.0% | -40.3% |
| Crecimiento BPA (anual) | | +5.3% | +0.6% | -35.2% | +88.0% | -4506.9% | +76.7% | +82.4% | -33.2% |
| Cambio en Acciones (anual) | | +0.0% | -1.6% | +4.6% | +589.4% | -94.3% | +499.3% | +483.3% | +5.3% |
| Crecimiento FCF (anual) | | -6.0% | +289.9% | -256.4% | +29.5% | -61.1% | -27.6% | -3.8% | -1.4% |
| Margen Bruto | | | 41.9% | 95.7% | | | | 100.0% | 33.0% |
| Margen Operativo | | | -71.4% | -74.5% | | | | -4047.1% | -1366.4% |
| Margen EBITDA | | | -62.0% | -67.3% | | | | -3890.1% | -1299.5% |
| Margen Neto | | | -64.8% | -71.7% | | | | -3680.4% | -1834.5% |
| Margen FCF | | | 114.5% | -140.2% | | | | -3433.6% | -1237.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.1% | -0.0% | -0.0% | -0.0% | -0.2% | -0.5% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-26.28 | $-27.84 | $53.74 | $-80.39 | $-8.22 | $-230.65 | $-49.12 | $-8.74 | $-8.42 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $627085 | $627085 | $616890 | $645064 | $4.4M | $255000 | $1.5M | $8.9M | $9.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -114.26% |
| Rentabilidad sobre capital invertido | -49.21% |
| Rentabilidad sobre activos | -65.25% |
| Margen bruto | 72.75% |
| Margen operativo | -3176.57% |
| Margen neto | -4477.08% |
Salud financiera
| Deuda / Patrimonio | 0.41 |
| Ratio corriente | 9.55 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -21.23 | -22.41 | -28.84 | -42.90 | -51.92 | -0.85 | -0.93 | -4.06 | -0.64 |
| P/VC | -14.49 | -8.90 | 3.23 | 5.91 | 8.72 | -0.50 | 0.44 | 2.12 | 1.46 |
| P/V | 0.00 | 0.00 | 18.68 | 30.75 | 0.00 | 0.00 | 0.00 | 149.54 | 11.77 |
| Margen Bruto | 0.0% | 0.0% | 41.9% | 95.7% | 0.0% | 0.0% | 0.0% | 100.0% | 33.0% |
| Margen Operativo | 0.0% | 0.0% | -71.4% | -74.5% | 0.0% | 0.0% | 0.0% | -4047.1% | -1366.4% |
| Margen Neto | 0.0% | 0.0% | -64.8% | -71.7% | 0.0% | 0.0% | 0.0% | -3680.4% | -1834.5% |